Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Micheva I, Gerov V, Dimitrova S, Efraim M. Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Case Rep Hematol 2021;2021:1717506. [PMID: 34136291 DOI: 10.1155/2021/1717506] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Accepted: 05/22/2021] [Indexed: 11/17/2022] Open

For:	Micheva I, Gerov V, Dimitrova S, Efraim M. Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Case Rep Hematol 2021;2021:1717506. [PMID: 34136291 DOI: 10.1155/2021/1717506] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Accepted: 05/22/2021] [Indexed: 11/17/2022] Open

Number

Cited by Other Article(s)

Hsieh PY, Wu SJ, Lin CP. Inotuzumab ozogamicin as a single agent to treat T315I-mutated chronic myeloid leukemia with acute blastic change to CD22+ acute lymphocytic leukemia. J Formos Med Assoc 2023;122:290-292. [PMID: 36529581 DOI: 10.1016/j.jfma.2022.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2022] [Revised: 12/01/2022] [Accepted: 12/02/2022] [Indexed: 12/23/2022] Open